Gujarat Themis Biosyn starts production in Fermentation Block at Vapi facility

18 Oct 2025 Evaluate

Gujarat Themis Biosyn has completed the expansion of its Fermentation Block at its manufacturing facilities at Vapi, Gujarat. The first batch of commercial production of Rifamycin-S and Rifamycin-O has commenced on October 18, 2025. 

With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL. This will further strengthen the company’s manufacturing capabilities to produce multiple fermentation products. With this capacity expansion, the company is in a strong position to capitalise on the significant growth opportunities in the fermentation segment.

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company.

Guj. Themis Biosyn Share Price

377.65 -9.95 (-2.57%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×